Market Overview

Options Brief: Cadence Pharmaceuticals


Shares of Cadence Pharmaceuticals (NASDAQ: CADX) are lower on the session by 1.15%, trading at $8.57.

Overall call volume is now running at 5.66x the daily average, with 77% of all calls traded being purchases on the offer. 2,005 contracts have traded on the session so far.

Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing product candidates for use in the hospital setting.

Posted-In: Options


Related Articles (CADX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→